5-Amino-1-(3-chlorophenyl)-1H-pyrazole-4-carbonitrile, 95.0%, 10g

1-(3-Nitropyridin-2-yl)piperidine-4-carboxamide, 97%, 1g

1-Benzhydrylazetidine, 95.0%, 100g

[2-(2-morpholin-4-ylethoxy)phenyl]acetic acid, 5g

4-Chloro-6-phenylfuro[2,3-d]pyrimidine, 97%, 100mg

(4S,5R)-3-(tert-Butoxycarbonyl)-2-(4-methoxyphenyl)-4-phenyloxazolidine-5-carboxylic acid, 95.0%, 5g

3-Nitroimidazo[1,2-a]pyridine, 97.0%, 250mg

(R)-5,7-Difluorochroman-4-ol, 97%, 1g

N-(tert-Butoxycarbonyl)-L-beta-homophenylalanine>98.0%(HPLC)(T)1g

Modelos de báscula de precisión Serie FX con calibración externa, 0,01 g, 1220 g, FX-1200i (W)

Recipiente de cristalización DURAN® sin pico, 40 ml, 50 mm, 10 Unidad(es)

tert-Butyl (2-(2,2-dimethyl-4H-benzo[d][1,3]dioxin-6-yl)-2-oxoethyl)carbamate, 98%, 250mg

CYCLOHEXANONE O-((6-((((CYCLOHEXYLIDENEAMINO)OXY)CARBONYL)AMINO)HEXYL)CARBAMOYL) OXIME, 95%, 50mg